Skip to main content

Nonprofit · EIN 04-3013709

NEUROFIBROMATOSIS INCORPORATED NORTHEAST

Tax-exempt · BURLINGTON, MA 01803

Financials

$559K$642K2023$676K$685K2024
Revenue Expenses · by fiscal year end
Financials of NEUROFIBROMATOSIS INCORPORATED NORTHEAST by year, from its e-filed returns
Year endedFormRevenueExpensesNet incomeTotal assetsLiabilitiesNet assets
December 31, 2024990$675,651$685,189-$9,538$900,101$131,594$768,507
December 31, 2023990$558,976$642,447-$83,471$784,530$25,453$759,077
Financial details: 990 for the year ended December 31, 2024

Revenue

Contributions, gifts and grants
$435,686
Program service revenue
$0
Investment income
$24,101
Net gain from sales of assets
$3,157
Net income from fundraising events
$213,723
Other revenue
$215,864

Expenses

Grants and similar amounts paid
$56,799
Compensation of officers, directors and key employees
$138,873
Other salaries and wages
$198,033
Salaries, compensation and benefits (total)
$368,840
Professional fundraising fees
$0
Accounting fees
$14,945
Occupancy
$38,003
Depreciation
$6,876
Program services (functional)
$396,527
Management and general (functional)
$141,373
Fundraising (functional)
$147,289

Balance sheet and other

Total assets, start of year
$814,413
Total assets, end of year
$900,101
Total liabilities, end of year
$131,594
Net assets, end of year
$768,507
Land, buildings and equipment
$8,468
Publicly traded securities
$351,565
Net assets without donor restrictions
$742,027
Net assets with donor restrictions
$26,480
Gross receipts
$910,829
Employees
8

From the e-filed returns the IRS publishes as XML (latest three processing years; amended returns replace the original). PDF copies at the IRS.

Officers, directors and key employees

As listed on the 990 for the year ended December 31, 2024, highest compensation first.

NameTitleHours / weekCompensationOther / benefits
SHARON KLEINEXECUTIVE DI
Officer
40$138,873$4,176
JOHN MANTHPRESIDENT
Trustee or director, Officer
1$0$0
ANDRES LESSINGTREASURER
Trustee or director, Officer
1$0$0
BENJAMIN BUTTRICKCLERK
Trustee or director, Officer
1$0$0
MARYBETH SHAWDIRECTOR
Trustee or director
1$0$0
LORI RYANDIRECTOR
Trustee or director
1$0$0
JOHN SHEADIRECTOR
Trustee or director
1$0$0
JUSTIN JORDANDIRECTOR
Trustee or director
1$0$0
FRANK BUONODIRECTOR
Trustee or director
1$0$0
ALEXANDRA CELLUCCIDIRECTOR
Trustee or director
1$0$0
PATRICK CALLAHANDIRECTOR
Trustee or director
1$0$0
NICOLE ULLRICHDIRECTOR
Trustee or director
1$0$0
JOHN THOMSONDIRECTOR
Trustee or director
1$0$0
THERESA OWHADYDIRECTOR
Trustee or director
1$0$0
KAREN PELUSODIRECTOR
Trustee or director
1$0$0
2 more people on this return
NameTitleHours / weekCompensation
KRISTINA RATHDIRECTOR
Trustee or director
1$0
TAMARA INDIANERDIRECTOR
Trustee or director
1$0
990 for the year ended December 31, 2023: 17 people
NameTitleHours / weekCompensationOther / benefits
SHARON KLEINEXECUTIVE DI
Officer
40$133,692$4,305
FRANK BUONODIRECTOR
Trustee or director
–$0$0
BEN BUTTRICKDIRECTOR
Trustee or director
–$0$0
PATRICK CALLAHANDIRECTOR
Trustee or director
–$0$0
ALEXANDRA POWERS CELLUCCIDIRECTOR
Trustee or director
–$0$0
TAMARA INDIANERDIRECTOR
Trustee or director
–$0$0
JUSTIN JORDANDIRECTOR
Trustee or director
–$0$0
ANDRES LESSINGDIRECTOR
Trustee or director
–$0$0
ANDRES LESSINGTREASURER
Trustee or director, Officer
–$0$0
MELISSA SHEA MALERBADIRECTOR/ SE
Trustee or director, Officer
–$0$0
JOHN MANTHCHAIRPERSON
Trustee or director, Officer
–$0$0
THERESA OWHADYDIRECTOR
Trustee or director
–$0$0
NICOLE ULLRICH MD PHDDIRECTOR
Trustee or director
–$0$0
KRISTINA RATHDIRECTOR
Trustee or director
–$0$0
MARYBETH SHAWDIRECTOR
Trustee or director
–$0$0
JOHN SHEADIRECTOR
Trustee or director
–$0$0
JOHN THOMSONDIRECTOR
Trustee or director
–$0$0

Address and contacts

Address (IRS master file)
9 BEDFORD ST 3RD FLOOR, BURLINGTON, MA 01803-3755
Principal officer (990 for 2024)
JOHN MANTH, 417 STANLEY STREET, NORTH TONAWANDA, NY 14120
Signed the 990
SHARON KLEIN, EXECUTIVE DIRECTOR
Phone
(781) 272-9936
Return prepared by
KING MCNAMARA MORIARTY LLP

Mission

THE DIAGNOSIS AND TREATMENT OF NEUROFIBROMATOSIS AND TO SUPPORT PROGRAMS INTENDED TO INCREASE AWARENESS OF NEUROFIBROMATOSIS.

990 for the year ended December 31, 2024

Program accomplishments

  • RESEARCH: SUPPORT AND RESEARCH WITH GRANTS FOR THE STUDY INTO THE CAUSES, TREATMENT AND CURE OF NEUROFIBROMATOSIS.
    Expenses $42,799 · grants $42,799
  • THE ORGANIZATION SERVES AS A VALUABLE RESOURCE FOR INDIVIDUALS AFFECTED BY NEUROFIBROMATOSIS, HELPING PATIENTS LOCATE EXPERIENCED PHYSICIANS AND SPECIALISTS. IT PROMOTES VOLUNTEER INVOLVEMENT AT EVENTS WHERE PATIENTS CAN CONNECT WITH OTHERS WHO SHARE SIMILAR EXPERIENCES. THROUGH ORGANIZED GATHERINGS, THE ORGANIZATION BRINGS TOGETHER PATIENTS, FAMILIES, AND FRIENDS TO SHARE MEDICAL UPDATES, RESEARCH DEVELOPMENTS, AND COMMUNITY SUPPORT. ADDITIONALLY, IT PROVIDES SCHOLARSHIPS FOR PERSONS WITH NEOUROFIBROMATOSIS TO CONTINUE THEIR EDUCATION AFTER HIGH SCHOOL AND TO PURSUE AN UNDERGRADUATE DEGREE.
    Expenses $328,728 · grants $14,000
  • LOBBYING: THE ORGANIZATION LOBBIED CONGRESS FOR INCREASED FUNDING FOR NEUROFIBROMATOSIS RESEARCH AT BOTH THE NATIONAL INSTITUTE OF HEALTH AND THE ARMY'S NEUROFIBROMATOSIS RESEARCH PROGRAM.
    Expenses $25,000

What it must file and when

IRS records say it files Form 990 or 990-EZ. Based on its last return; a smaller organization may file the 990-N. Its accounting year ends in December, so each return is due on the 15th day of the 5th month after that.

Tax yearYear endedDueIRS public records
2025December 31, 2025May 15, 2026Not on file
2024December 31, 2024May 15, 2025990 on file
2023December 31, 2023May 15, 2024990 on file

IRS record

EIN
04-3013709
Tax-exempt status
501(c)(3): Charitable, religious, educational or scientific organization
Foundation status
Publicly supported organization (509(a)(2))
Donations deductible (Pub 78)
Public charity, 50% deduction limit
Exempt since
1989
Accounting year ends
December
Files
Form 990 or 990-EZ
Assets (IRS master file)
$900,101
Income (IRS master file)
$910,829

Filing history

FormYear endedRevenueExpensesAssetsReturn
990December 2024$675,651$685,189$900,101XML
990December 2023$558,976$642,447$784,530XML
990December 2022$616,977$651,825$842,757IRS
990December 2021–––IRS
990December 2020–––IRS
990December 2018–––IRS
990December 2017–––IRS

990-N: the IRS bulk file holds only the latest e-Postcard per organization; earlier years come from archived copies of that file since 2020 and can have gaps (the IRS e-Postcard search lists every one). 990, 990-EZ, 990-PF, 990-T: every e-filed return in the IRS e-file index since 2019; XML for the latest three processing years, amounts from the IRS Statistics of Income extracts before that. PDF copies and determination letters at the IRS (search EIN 04-3013709).

Questions about NEUROFIBROMATOSIS INCORPORATED NORTHEAST

What is the EIN of NEUROFIBROMATOSIS INCORPORATED NORTHEAST?
The employer identification number (EIN) of NEUROFIBROMATOSIS INCORPORATED NORTHEAST is 04-3013709.
Is NEUROFIBROMATOSIS INCORPORATED NORTHEAST tax-exempt?
Yes. The IRS lists it as tax-exempt under section 501(c)(3) since 1989.
Are donations to NEUROFIBROMATOSIS INCORPORATED NORTHEAST tax-deductible?
Yes. It is listed in IRS Publication 78 (Public charity, 50% deduction limit).
Which annual return does NEUROFIBROMATOSIS INCORPORATED NORTHEAST file?
Form 990 or 990-EZ. Based on its last return; a smaller organization may file the 990-N.
When is the next return of NEUROFIBROMATOSIS INCORPORATED NORTHEAST due?
The return for tax year 2025 (the year ending December 31, 2025) is due May 15, 2026. Form 8868 extends it by six months; the 990-N cannot be extended.
When did NEUROFIBROMATOSIS INCORPORATED NORTHEAST last file with the IRS?
The latest return in the IRS public files is the 990 for the year ended December 2024.
Who is the principal officer of NEUROFIBROMATOSIS INCORPORATED NORTHEAST?
The 990 for the year ended December 31, 2024 names JOHN MANTH.
Who are the officers and directors of NEUROFIBROMATOSIS INCORPORATED NORTHEAST?
The 990 for the year ended December 31, 2024 lists 17 people; 1 received compensation from the organization, the highest $138,873 (SHARON KLEIN, EXECUTIVE DI).
How much revenue does NEUROFIBROMATOSIS INCORPORATED NORTHEAST have?
On its 990 for the year ended December 31, 2024 it reported revenue of $675,651, expenses of $685,189 and total assets of $900,101 at year end.

Other nonprofits in BURLINGTON

All nonprofits in BURLINGTON · Massachusetts